A Trial of Lu AH69593 in Healthy Participants

Sex: All

Ages: 18 Years – 55 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 46

Sponsor: H. Lundbeck A/S

Location: Fortrea Clinical Research Unit Ltd (Labcorp Clinical Research Unit Limited) Madison Wisconsin

Summary

This trial will evaluate the effects of itraconazole (Part A) and, carbamazepine (Part B) on Lu AH69593, and the effect of Lu AH69593 on midazolam (Part C) in adult healthy participants. The main goals of this trial are to learn about 1. the effect of other medicines on Lu AH69593 2. the pharmacokinetic parameters of Lu AH69593 (how the drug is absorbed, distributed, and processed by the body), and 3. the safety and tolerability of Lu AH69593.

Eligibility Criteria

Key Inclusion Criteria: * The participant is, in the opinion of the investigator, generally healthy based on medical history, a physical examination, a neurological examination, vital signs, an electrocardiogram (ECG), and the results of the clinical chemistry, haematology, urinalysis, serology, and other laboratory tests. * The participant is willing and able to attend trial appointments within the specified time windows. * The participant is willing to be an inpatient from the Baseline Visit to the Completion Visit. Key Exclusion Criteria: * The participant has taken any investigational medicinal product (IMP) \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07775261). StuddyBuddy aggregates publicly available trial information.